Purchase Order AG91H2P11AA050

Award Date 3/29/11
Potential Completion Date 4/11/11
Potential Value $5K
Federal Agency
Pacific West Area
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...
This federal contract award was issued by the Food and Drug Administration (FDA) to the American Type Culture Collection (ATCC), a nonprofit biological resource center, for the cryopreservation and storage of two cell lines infected with a retrovirus. The contract, valued at $73,529.00, is a firm-fixed price purchase order with an ultimate completion date of August 22, 2025. The original solicitation, which was issued as full and open competition, requested the expansion, vial preparation,...
The U.S. government's Midwest Area agency awarded a $34,465.20 firm fixed price purchase order contract to Envigo Bioproducts Inc., a subsidiary of Inotiv, Inc., for the cryostorage of 154 vials of hybridoma cell lines. This contract has a completion date of July 31, 2027 and was awarded on August 1, 2022. Envigo Bioproducts Inc. has previously provided specialized biomedical services including hybridoma production, antibody production, and cell line storage to the Department of Agriculture...
Mediatech, Inc., doing business as Cellgro, was awarded a $6,000 firm fixed price purchase order as the prime contractor to provide various cell culture media, reagents, enzymes, and related laboratory supplies to the National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH). The products will support research being conducted by Dr. Ajay Sharma at NICHD's facilities in Sudley Springs, Virginia. Cellgro is a subsidiary of Corning Incorporated...
The Centers for Disease Control and Prevention (CDC) awarded a $249,662 purchase order to Cell Microsystems Inc. to procure cell lines in support of the agency's biomedical research and public health initiatives. The firm fixed price contract has a period of performance from September 11, 2023 through October 30, 2023 for delivery of the requested cell lines to CDC facilities in Durham, North Carolina. No subcontractors or set aside designations were identified. This award advances the CDC's...
This is a firm fixed-price purchase order contract awarded by the Uniformed Services University of the Health Sciences, a defense agency, to Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit UND Umwelt (Gmbh), a non-profit research organization, for the purchase of mutant ES cell clones. The contract has a ceiling value of $2,019.04 and a completion date of February 8, 2010. No set-aside designation was used. The awardee, Helmholtz Zentrum Muenchen Deutsches...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Fisher Bioservices Inc. Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract, with a ceiling value of $2,056,460.02, is for repository services to support the MFMU Specimens program, which likely involves the management and storage of biological specimens collected during research studies. The contract is a Delivery Order, with a Cost...

DEPOSITION OF TWO HYDRIDOMA CELL LINES, MCS 6-27 AND MCS 92-32-1-10,AS PART OF A PATENT APPLICATION.

Posted 3/29/11, 12:00 AM